VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AUPH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AUPHAurinia Pharmaceuticals Inc.
$15.49$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAUPHQuarterly Financials

Aurinia Pharmaceuticals Inc. (AUPH) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Aurinia Pharmaceuticals Inc. (AUPH) quarterly income statement — complete revenue, gross profit & net income history

AUPH Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue77.7M77.11M73.47M70.01M62.47M59.87M67.77M57.19M50.3M45.09M54.52M41.49M34.41M28.43M55.78M28.19M21.63M23.4M14.67M6.62M
Revenue Growth %24.4%28.81%8.41%22.41%24.18%32.76%24.32%37.83%46.19%58.59%-2.27%47.19%59.12%21.5%280.3%325.85%2265.97%-53.22%50475.86%22727.59%
Cost of Goods Sold6.5M8.47M8.5M7.12M8.57M5.55M6.04M8.91M7.75M5.39M6.77M1.56M421K1.36M2.45M1.6M256K481K254K308K
COGS % of Revenue8.37%10.99%11.58%10.16%13.73%9.27%8.91%15.58%15.41%11.96%12.42%3.77%1.22%4.79%4.39%5.67%1.18%2.06%1.73%4.65%
Gross Profit71.2M68.64M64.96M62.89M53.89M54.31M61.74M48.28M42.55M39.7M47.75M39.93M33.99M27.07M53.33M26.59M21.37M22.92M14.41M6.31M
Gross Margin %91.63%89.01%88.42%89.84%86.27%90.73%91.09%84.42%84.59%88.04%87.58%96.23%98.78%95.21%95.61%94.33%98.82%97.94%98.27%95.35%
Gross Profit Growth %32.12%26.38%5.23%30.26%26.65%36.81%29.3%20.92%25.19%46.64%-10.47%50.16%59.05%18.1%270.03%321.29%2367.55%-54.18%49600%21665.52%
Operating Expenses29.78M35.4M35.22M42.81M32.04M55.98M49.99M49.8M53.25M69.37M64.01M56.1M63.57M55.17M62.83M62.58M59.25M55.63M64.77M53.45M
OpEx % of Revenue38.32%45.91%47.94%61.15%51.3%93.51%73.76%87.07%105.85%153.84%117.42%135.2%184.75%194.03%112.64%221.99%273.99%237.69%441.58%807.34%
Selling, General & Admin22.03M29.25M26.18M26.02M20.34M45.26M42.37M44.93M47.7M50.07M47.76M43.64M50.12M47.47M52.17M51.53M45.2M44.24M44.65M44.32M
SG&A % of Revenue28.35%37.94%35.64%37.16%32.56%75.6%62.51%78.57%94.82%111.04%87.61%105.17%145.67%166.95%93.53%182.8%209%189.04%304.39%669.52%
Research & Development7.47M10.89M8.44M7.43M5.74M8.11M3.05M4.08M5.55M10.23M13.61M12.65M13.16M9.87M10.97M11.53M12.62M11.15M20.07M10.09M
R&D % of Revenue9.61%14.13%11.48%10.62%9.19%13.54%4.5%7.13%11.04%22.68%24.96%30.49%38.24%34.71%19.67%40.88%58.36%47.64%136.81%152.43%
Other Operating Expenses279K-1000K602K1000K1000K1000K1000K782K01000K1000K-190K290K-1000K-311K-476K1000K237K55K-967K
Operating Income41.42M33.24M29.75M20.08M21.85M-1.67M11.75M-1.51M-10.7M-29.67M-16.26M-16.17M-29.58M-28.1M-9.5M-35.99M-37.88M-32.7M-50.35M-47.13M
Operating Margin %53.31%43.1%40.49%28.69%34.97%-2.79%17.33%-2.65%-21.26%-65.8%-29.83%-38.97%-85.98%-98.82%-17.03%-127.66%-175.18%-139.74%-343.31%-711.99%
Operating Income Growth %89.6%2091.55%153.19%1427.36%304.27%94.38%172.24%90.64%63.85%-5.6%-71.21%55.07%21.9%14.08%81.14%23.65%25.05%-306.17%-19%-75.46%
EBITDA46.24M38.1M34.61M24.95M26.7M3.19M16.64M3.33M-5.85M-24.73M-10.81M-15.45M-28.87M-27.88M-8.69M-35M-37.04M-32.02M-49.59M-46.29M
EBITDA Margin %59.5%49.41%47.11%35.63%42.75%5.33%24.55%5.82%-11.63%-54.83%-19.83%-37.24%-83.89%-98.05%-15.58%-124.15%-171.3%-136.8%-338.09%-699.18%
EBITDA Growth %73.16%1093.33%107.98%649.16%556.62%112.91%253.97%121.55%79.74%11.32%-24.37%55.85%22.07%12.92%82.48%24.39%26.1%-310.47%-18.59%-74.37%
D&A (Non-Cash Add-back)4.82M4.86M4.87M4.86M4.86M4.86M4.89M4.84M4.85M4.95M5.46M719K717K219K809K991K838K688K766K848K
EBIT44.94M42.2M31.96M23.27M25.42M2.32M16.02M2.68M-8.73M-25.11M-11.75M-12.07M-25.77M-28.1M-8.04M-35.51M-37.88M-32.7M-50.35M-47.13M
Net Interest Income2.5M-1.92M2.22M2.07M2.5M2.84M3.06M2.99M3.24M3.26M3.11M4.04M3.81M2.91M1.46M483K262K109K106K142K
Interest Income3.52M4.6M2.22M3.19M3.57M3.99M4.27M4.19M4.53M4.57M4.51M4.1M3.81M2.91M1.46M483K262K109K106K142K
Interest Expense1.01M6.51M01.12M1.07M1.15M1.21M1.2M1.28M1.31M1.4M65K00000000
Other Income/Expense2.5M2.45M2.22M2.07M2.5M2.84M3.06M2.99M685K3.26M3.11M4.04M3.81M2.91M1.46M483K262K109K106K142K
Pretax Income43.92M35.69M31.96M22.16M24.35M1.17M14.81M1.48M-10.01M-26.42M-13.15M-12.13M-25.77M-25.19M-8.04M-35.51M-37.62M-32.6M-50.25M-46.99M
Pretax Margin %56.53%46.28%43.5%31.65%38.98%1.96%21.85%2.58%-19.9%-58.58%-24.12%-29.24%-74.89%-88.59%-14.41%-125.95%-173.97%-139.28%-342.59%-709.85%
Income Tax9.57M-175.1M411K643K1M-256K457K756K739K459K298K-642K436K855K954K9K10K726K8K18K
Effective Tax Rate %21.79%-490.62%1.29%2.9%4.13%-21.82%3.09%51.15%-7.38%-1.74%-2.27%5.29%-1.69%-3.39%-11.87%-0.03%-0.03%-2.23%-0.02%-0.04%
Net Income34.35M210.79M31.55M21.51M23.34M1.43M14.35M722K-10.75M-26.88M-13.45M-11.49M-26.21M-26.05M-8.99M-35.52M-37.63M-33.32M-50.26M-47.01M
Net Margin %44.21%273.35%42.95%30.73%37.37%2.39%21.17%1.26%-21.37%-59.6%-24.67%-27.7%-76.16%-91.6%-16.12%-125.98%-174.01%-142.38%-342.64%-710.12%
Net Income Growth %47.17%14651.15%119.87%2879.64%317.17%105.32%206.72%106.28%58.98%-3.18%-49.59%67.64%30.36%21.84%82.11%24.45%25.31%-312.71%-19.29%-77.1%
Net Income (Continuing)34.35M210.79M31.55M21.51M23.34M1.43M14.35M722K-10.75M-26.88M-13.45M-11.49M-26.21M-26.05M-8.99M-35.52M-37.63M-33.32M-50.26M-47.01M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.251.530.230.150.160.010.100.01-0.07-0.19-0.09-0.08-0.18-0.18-0.06-0.25-0.27-0.25-0.39-0.37
EPS Growth %56.25%15200%133.5%1400%314.48%105.26%204.68%112.5%58.56%-5.56%-48.42%68%33.33%28%83.74%32.43%32.5%-316.67%-14.71%-54.17%
EPS (Basic)0.261.580.240.160.160.010.100.01-0.07-0.19-0.09-0.08-0.18-0.18-0.06-0.25-0.27-0.25-0.39-0.37
Diluted Shares Outstanding137.64M138.7M136.01M143.2M138.92M147.68M145.65M144.11M144.01M143.62M142.85M142.78M142.64M142.27M141.86M141.73M141.68M132.05M128.44M128.22M
Basic Shares Outstanding132.38M134.37M137.18M138.92M138.92M142.18M143.05M143.33M144.01M143.62M142.85M142.78M142.64M142.27M141.86M141.73M141.68M132.05M128.44M128.22M
Dividend Payout Ratio--------------------